Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2024-04797 | Registry Identifier | CTRP (Clinical Trial Reporting Program) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.
PRIMARY OBJECTIVE:
I. To describe the impact of SAS training on participants' responses to people with a substance impairment.
SECONDARY OBJECTIVES:
I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel.
II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes.
OUTLINE: Participants are randomized to 1 of 6 group case vignettes.
GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study.
GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study.
GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study.
GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study.
GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study.
GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A (chronically relapsing brain disease vignette, SAS) | Experimental | Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study. |
|
| Group B (brain disease vignette, SAS) | Experimental | Participants view the brain disease vignette and attend a SAS workshop on study. |
|
| Group C (disease vignette, SAS) | Experimental | Participants view the disease vignette and attend a SAS workshop on study. |
|
| Group D (illness vignette, SAS) | Experimental | Participants view the illness vignette and attend a SAS workshop on study. |
|
| Group E (disorder vignette, SAS) | Experimental | Participants view the disorder vignette and attend a SAS workshop on study. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessment | Behavioral | Ancillary studies |
|
| Measure | Description | Time Frame |
|---|---|---|
| Stigmatizing attitudes | Stigmatizing attitudes will be measured with the Stigma and Attribution Assessment. The assessment score will be compared both between and within participants for each case vignette. Results will be reported with descriptive statistics, including means and standard deviations or medians and first-third quartiles for continuous variables, and frequencies and percentages for discrete variables.The linear mixed effect model will be used to study the repeated stigma and attribution measures over time (pre-workshop, immediately post-workshop, and 8 weeks post-workshop) within 6 vignettes as well as the effects between the vignettes, while controlling for the potential confounding factors (e.g., sex). | Before, immediately after and 8 weeks after the session |
| Measure | Description | Time Frame |
|---|---|---|
| Attendance rate | The proportion of participants attending the workshop will be summarized with 95% confidence interval. | At 90 minute session. |
| Response to post-workshop evaluations | The proportion of participants who respond to the post-workshop evaluations will be summarized with 95% confidence interval. |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gretchen A Mcnally, PhD, APRN-CNP | Ohio State University Comprehensive Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States |
Not provided
| Label | URL |
|---|---|
| The Jamesline | View source |
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Sep 29, 2023 | Aug 28, 2024 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D012149 | Restraint, Physical |
| D017063 | Outcome Assessment, Health Care |
| D064887 | Observational Studies as Topic |
| D055070 | Resistance Training |
| ID | Term |
|---|---|
| D032763 | Behavior Control |
| D013812 | Therapeutics |
| D007103 | Immobilization |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Group F (problem vignette, SAS) | Experimental | Participants view the problem vignette and attend a SAS workshop on study. |
|
|
| Educational Activity | Other | View the chronically relapsing brain disease vignette |
|
| Educational Activity | Other | View the brain disease vignette |
|
| Educational Activity | Other | View the disease vignette |
|
| Educational Activity | Other | View the illness vignette |
|
| Educational Activity | Other | View the disorder vignette |
|
| Educational Activity | Other | View the problem vignette |
|
| Training | Other | Attend a SAS workshop |
|
|
| Before, immediately following and 8 weeks after the session. |
| D010043 |
| Outcome and Process Assessment, Health Care |
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017531 | Health Care Evaluation Mechanisms |
| D017530 | Health Care Quality, Access, and Evaluation |
| D000068456 | Clinical Studies as Topic |
| D016020 | Epidemiologic Study Characteristics |
| D004812 | Epidemiologic Methods |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
| D005081 | Exercise Therapy |
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
| D026741 | Physical Therapy Modalities |
| D064797 | Physical Conditioning, Human |
| D015444 | Exercise |
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |